STE - STERIS plc

NYSE - Nasdaq 即時價格。貨幣為 USD。

STERIS plc

70 Sir John Rogerson’s Quay
Dublin 2
Dublin D02 R296
Ireland
353 1 232 2000
https://www.steris.com

版塊Healthcare
行業Medical Devices
全職員工17,000

高階主管

名稱標題支付行使價出生年份
Mr. Daniel A. CarestioPres, CEO & Director1.63M1973
Mr. Michael J. TokichSr. VP & CFO1.03M8.49M1969
Mr. John Adam ZangerleSr. VP, Gen. Counsel & Sec.800.03k1967
Mr. Walter M. Rosebrough Jr.CEO Emeritus & Sr. Advisor1.16M8.04M1954
Mr. Cary L. MajorsSr. VP & Pres of Healthcare734.37k1.05M1975
Mr. Andrew XilasSr. VP & GM of Dental1.44M1965
Ms. Karen L. BurtonChief Accounting Officer, VP & Controller1968
Julie WinterVP of Investor Relations & Corp. Communications
Ms. Mary Clare FraserSVP & Chief HR Officer1970
Ms. Julia K. MadsenSr. VP of Life Sciences1965
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

公司管治

截至 2023年6月1日 止,STERIS plc 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:8;董事會:3;股東權利:7;現金賠償:6。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。